InsidersTradesSigma
Total declarations
Company
▲ Purchases (7 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
7
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Temperato John, Chief Executive Officer. Director active across 1 company, notably 9 METERS BIOPHARMA, INC.. Aggregated, 8 disclosures have been logged. Split: 7 buys · 0 sell. Total volume traded: €237k. Activity tracked since 18 August 2021. The latest transaction was disclosed on 6 July 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
68,815 sharesCommon StockSEC:0001578563-23-000008:0
125,000 shares@ US$0.227711.8% of flowCommon stockSEC:0001551986-22-000070:0
Ideal exit: 2 Apr 2023 (T+270)
50,000 shares@ US$0.445710.2% of flowCommon StockSEC:0001578563-22-000017:0
Ideal exit: 12 Feb 2023 (T+270)
100,000 shares@ US$0.555923.9% of flowCommon stockSEC:0001551986-22-000021:0
Ideal exit: 28 Nov 2022 (T+270)
50,000 shares@ US$1.0522.2% of flowCommon stockSEC:0001551986-21-000120:0
Ideal exit: 15 Aug 2022 (T+270)
50,000 shares@ US$1.0519.6% of flowCommon stockSEC:0001551986-21-000120
Ideal exit: 15 Aug 2022 (T+270)
25,000 shares@ US$1.0510.7% of flowCommon stockSEC:0001551986-21-000095:0
Ideal exit: 15 May 2022 (T+270)
25,000 shares@ US$1.059.5% of flowCommon stockSEC:0001551986-21-000095
Ideal exit: 15 May 2022 (T+270)
8 of 8 declarations
About Temperato John
John Temperato is Chief Executive Officer at 9 Meters Biopharma, Inc. He is responsible for the strategic direction of the company and the management of daily operations. His leadership is essential for achieving the company's growth and innovation objectives.
